Laboratory-based surveillance of chronic kidney disease in people with private health coverage in Brazil

• Published in: BMC nephrology Vol. 25; no. 1; pp. 162 - 10
• Main Authors: Samaan, Farid, Silveira, Rubens Carvalho, Mouro, Amilton, Kirsztajn, Gianna Mastroianni, Sesso, Ricardo
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 10.05.2024; BioMed Central; BMC
• Subjects: Adolescent; Adult; Age; Aged; Analysis; Brazil - epidemiology; Chronic kidney disease; Chronic kidney failure; Creatinine; Creatinine - blood; Emergency medical care; Epidemiology; Female; Females; Gender; Global health; Glomerular Filtration Rate; Health care policy; Humans; Information systems in clinical laboratory; Insurance coverage; Insurance, Health - statistics & numerical data; Kidney diseases; Laboratories; Male; Medical care, Cost of; Middle Aged; Population; Population Surveillance - methods; Prevalence; Prevention; Proteinuria; Proteinuria - epidemiology; Public health; Renal Insufficiency, Chronic - epidemiology; Renal replacement therapy; Risk factors; Sex differences; Supplementary health; Young Adult; Brazil; Supplementary health; Chronic kidney disease; Prevalence; Information systems in clinical laboratory; Epidemiology
• ISSN: 1471-2369; 1471-2369
• DOI: 10.1186/s12882-024-03597-9

Although approximately 25% of Brazilians have private health coverage (PHC), studies on the surveillance of chronic kidney disease (CKD) in this population are scarce. The objective of this study was to estimate the prevalence of CKD in individuals under two PHC regimes in Brazil, who total 8,335,724 beneficiaries. Outpatient serum creatinine and proteinuria results of individuals from all five regions of Brazil, ≥ 18 years of age, and performed between 10/01/2021 and 10/31/2022, were analyzed through the own laboratory network database. People with serum creatinine measurements were evaluated for the prevalence and staging of CKD, and those with simultaneous measurements of serum creatinine and proteinuria were evaluated for the risk category of the disease. CKD was classified according to current guidelines and was defined as a glomerular filtration rate (GFR) < 60 ml/min/1.73 m² estimated by the 2021 CKD-EPI equation. The number of adults with serum creatinine results was 1,508,766 (age 44.0 [IQR, 33.9-56.8] years, 62.3% female). The estimated prevalence of CKD was 3.8% (2.6%, 0.8%, 0.2% and 0.2% in CKD stages 3a, 3b, 4 and 5, respectively), and it was higher in males than females (4.0% vs. 3.7%, p < 0.001, respectively) and in older age groups (0.2% among 18-29-year-olds, 0.5% among 30-44-year-olds, 2.0% among 45-59-year-olds, 9.4% among 60-74-year-olds, and 32.4% among ≥ 75-year-olds, p < 0.001) Adults with simultaneous results of creatinine and proteinuria were 64,178 (age 57.0 [IQR, 44.8-67.3] years, 58.1% female). After adjusting for age and gender, 70.1% were in the low-risk category of CKD, 20.0% were in the moderate-risk category, 5.8% were in the high-risk category, and 4.1% were in the very high-risk category. The estimated prevalence of CKD was 3.8%, and approximately 10% of the participants were in the categories of high or very high-risk of the disease. While almost 20% of beneficiaries with PHC had serum creatinine data, fewer than 1% underwent tests for proteinuria. This study was one of the largest ever conducted in Brazil and the first one to use the 2021 CKD-EPI equation to estimate the prevalence of CKD.